Illustrative

Trump Abandons 'FDA for AI' Proposal

Tech Policy Press·May 22

✦ NabkaNews BriefAuto-summarized from multiple outlets · verify with the source

A proposal referred to as 'FDA for AI' has been abandoned. The decision to abandon the proposal has been made, however details about the proposal and its intended purpose are not specified. The outcome of this abandonment is also not clear.

Full coverage

The end of compounded GLP-1 copies leaves many patients in a ‘lose-lose’ position

STAT·Apr 29

View original report at Tech Policy Press ↗

Fetching the latest headlines…

Trump Abandons 'FDA for AI' Proposal

Full coverage

Trump revives pharma tariffs with 100% charges, but leaves loopholes

FDA backs off stricter tanning bed rules with RFK Jr.'s support

Trump Signs Previously Shelved AI Executive Order

Drug and medical device regulation under the Trump administration

FDA leaders moving to abandon advisory committee reviews of specific new drugs

May 2026 US Tech Policy Roundup

Vinay Prasad’s ouster leaves biotech guessing at FDA direction

The end of compounded GLP-1 copies leaves many patients in a ‘lose-lose’ position